Genetic robustness, or the ability of an organism to maintain fitness in the presence of harmful mutations, can be achieved via protein feedback loops. Previous work has suggested that organisms may also respond to mutations by transcriptional adaptation, a process by which related gene(s) are upregulated independently of protein feedback loops. However, the prevalence of transcriptional adaptation and its underlying molecular mechanisms are unknown. Here, by analysing several models of transcriptional adaptation in zebrafish and mouse, we uncover a requirement for mutant mRNA degradation. Alleles that fail to transcribe the mutated gene do not exhibit transcriptional adaptation, and these alleles give rise to more severe phenotypes than alleles displaying mutant mRNA decay. Transcriptome analysis in alleles displaying mutant mRNA decay reveals the upregulation of a substantial proportion of the genes that exhibit sequence similarity with the mutated gene's mRNA, suggesting a sequence-dependent mechanism. These findings have implications for our understanding of disease-causing mutations, and will help in the design of mutant alleles with minimal transcriptional adaptation-derived compensation.
1
, rewiring of genetic networks 2 and, in the case of rapidly proliferating organisms such as yeast, the acquisition of adaptive mutations 3 . In a previous report 4 , we proposed genetic compensation-and specifically, transcriptional adaptation 5 -as another underlying mechanism. According to this model, a mutation can lead to the increased expression of related genes that are themselves able to assume the function of the mutated gene. We provided evidence that this increased expression could be induced by a process upstream of the loss of protein function, indicating the existence of an unknown trigger. Here, to investigate the underlying molecular machinery, we developed and investigated several models of transcriptional adaptation in zebrafish and mouse.
Transcriptional adaptation in zebrafish and mouse
We began by analysing different zebrafish and mouse mutants that either have a premature termination codon (PTC) or have their last exon deleted (Extended Data Fig. 1 ). In zebrafish, hbegfa, vcla, hif1ab, vegfaa, egfl7 and alcama mutants exhibit increased mRNA expression levels of a gene paralogue or family member (hereafter referred to as 'adapting gene'), namely, hbegfb, vclb, epas1a and epas1b, vegfab, emilin3a and alcamb, respectively (Fig. 1a) . Injection of wild-type hif1ab, vegfaa, egfl7 and alcama mRNA into the respective mutants did not have any effect on this transcriptional adaptation response (Extended Data Fig. 2a ), suggesting that it is triggered upstream of the loss of protein function. Moreover, we found that vcla, hif1ab and egfl7 heterozygous animals also displayed transcriptional adaptation, albeit less pronounced than that observed in the homozygous mutants (Extended Data Fig. 2b ), indicating that transcriptional adaptation is a dominant phenomenon. Notably, we also observed an upregulation of the wild-type allele in hbegfa, hif1ab, vegfaa and alcama heterozygous embryos (Extended Data Fig. 2c ). Similarly, we found that Fermt2 (also known as Kindlin-2) mutant mouse kidney fibroblasts (MKFs), Rela and Actg1 mutant mouse embryonic fibroblasts (MEFs) and Actb mutant mouse embryonic stem cells (mESCs) (hereafter referred to as the knockout alleles) displayed increased mRNA levels of Fermt1 (also known as Kindlin-1), Rel, Actg2 and Actg1, respectively (Fig. 1b) . Transfection of wild-type Fermt2 and Rela in the respective knockout cells did not dampen the transcriptional adaptation response (Extended Data Fig. 2d-f ), and we also found that Actb heterozygous mESCs upregulated Actg1 (Extended Data Fig. 2g ). Altogether, these data strongly indicate that the loss of protein function is not the trigger for the transcriptional adaptation response observed in these models.
To determine whether the increased mRNA expression levels were caused by increased transcription of the adapting gene or increased mRNA stability, we measured the precursor mRNA (pre-mRNA) levels of hbegfb and emilin3a in hbegfa and egfl7 zebrafish mutants, and found that they were also upregulated (Extended Data Fig. 3a) . Similar findings were obtained for Fermt1 and Rel pre-mRNA expression levels in Fermt2 and Rela knockout mouse cells (Extended Data  Fig. 3b ). Together, these data indicate an increase in transcription of the adapting genes. In addition, Fermt2 knockout MKFs displayed increased chromatin accessibility at the Fermt1 transcription start site (TSS), as observed by the assay for transposase-accessible chromatin with high-throughput sequencing (ATAC-seq) (Extended Data Fig. 3c ).
Article reSeArcH zebrafish studies, we identified several mutant alleles that did not display transcriptional adaptation (Extended Data Fig. 3d-f ), indicating that a DNA lesion by itself is not sufficient to trigger transcriptional adaptation, or that specific DNA lesions are required. Notably, while analysing various mutant alleles, we found that unlike hbegfa Δ7 and vcla
Δ13
, two other PTC-bearing alleles, hbegfa sa18135 and vcla sa14599 , did not display transcriptional adaptation (Fig. 1c, Extended Data Fig. 1 ). To investigate the reason for this difference, we examined mutant mRNA levels and observed limited or no decrease in mRNA expression levels for the hbegfa sa18135 and vcla sa14599 alleles compared to wild type (Fig. 1d) . This correlation between a decrease in mutant mRNA levels and transcriptional adaptation was observed for all alleles examined (Fig. 1e , f, Extended Data Fig. 3d-f ). To determine whether the decreased mRNA levels were caused by decreased transcription or by reduced stability, we analysed pre-mRNA expression levels of hbegfa, egfl7 and alcama in hbegfa Δ7 , egfl7 and alcama mutants. We found that pre-mRNA expression levels remained unchanged or were slightly upregulated compared to wild type, in contrast with the mRNA levels (Extended Data Fig. 4a ). Similar findings were observed in Fermt2 and Rela knockout mouse cells (Extended Data Fig. 4b) . Moreover, metabolic labelling of newly synthesized transcripts revealed similar or increased levels of Fermt2, Rela and Actg1 mutant transcripts compared to wild type (Extended Data Fig. 4c ), while transcription inhibition assays showed that the mutant transcripts had shorter halflives (Extended Data Fig. 4d-f) . Together, these data indicate that mutants that exhibit transcriptional adaptation have reduced mutant mRNA levels because of mRNA decay.
To investigate the role of the mRNA surveillance machinery in transcriptional adaptation, we genetically inactivated the key nonsense-mediated decay (NMD) factor Upf1 6 in hbegfa Δ7 , vegfaa and vcla Δ13 zebrafish mutants. Inactivating upf1 in these mutants led to a reduction in mutant mRNA decay (Extended Data Fig. 5a ), and loss of transcriptional adaptation (Fig. 2a) . We also observed a decrease in, or loss of, transcriptional adaptation in Rela and Actb knockout mouse cells when we knocked down proteins involved in the mRNA surveillance machinery (Fig. 2b, c, Extended Data Fig. 5b, c) . Pharmacological inhibition of NMD in hbegfa Δ7 zebrafish mutants (Extended Data Fig. 5d , e), and blocking translation in Rela knockout mouse cells (an alternative approach to inhibit mRNA decay) (Extended Data Fig. 5f, g ) led to similar observations. We next investigated whether inducing mRNA degradation in wild-type zebrafish or in mouse cells by using uncapped RNAs, which are known to be rapidly degraded by 5′-to-3′ exonucleases 7 , could trigger transcriptional adaptation. Indeed, injection of uncapped hif1ab or vegfaa RNAs into wild-type embryos induced transcriptional adaptation (Fig. 2d) , including an increase in endogenous hif1ab and vegfaa expression (Extended Data Fig. 5h) . Similarly, transfection of uncapped Actb RNA into wild-type mESCs led to Actg1 upregulation (Extended Data Fig. 5i ). Moreover, injecting wild-type embryos with uncapped hif1ab or vegfaa RNAs containing an upstream sequence that renders them resistant to 5′-to-3′ exonuclease-mediated decay 8 did not induce transcriptional adaptation (Extended Data Fig. 5j ). Altogether, these data indicate that mRNA degradation is a major factor in triggering transcriptional adaptation. Notably, injection of uncapped RNA that was synthesized from the non-coding strand of hif1ab or vegfaa did not lead to an increase in epas1a or vegfab mRNA expression levels (Extended Data Fig. 5k ), suggesting that the RNA sequence itself may have a role in transcriptional adaptation.
If mutant mRNA degradation is required for transcriptional adaptation, alleles that fail to transcribe the mutated gene should not display this response. To this end, we used CRISPR-Cas9 to generate such alleles (hereafter referred to as RNA-less alleles) by deleting promoter regions or the entire gene locus. RNA-less alleles of hbegfa, vegfaa and alcama failed to upregulate hbegfb, vegfab and alcamb, respectively (Fig. 3a) . Similarly, in mouse cells, RNA-less alleles of Rela, Actg1 and Actb did not upregulate the adapting gene (Fig. 3b) . We also attempted to generate a promoter-less allele of Fermt2 in MKFs; however, the obtained clones exhibited proliferation defects that prevented their expansion. As an alternative, we used CRISPR interference (CRISPRi) and found that reducing transcription of the mutant Fermt2 gene in Fermt2 knockout cells led to a decrease in Fermt1 mRNA expression levels (Extended Data Fig. 6a) . Notably, we observed that the promoterless Rela MEFs were more sensitive to TNF-induced apoptosis 9 than the Rela knockout MEFs (Fig. 3c) . Similarly, mESCs with a full locus deletion of Actb displayed less protrusive activity than Actb knockout cells (Fig. 3d, e) . We also generated an egfl7 RNA-less allele in zebrafish and observed that these mutants displayed pronounced vascular defects (Fig. 3f, g ), and milder upregulation of the emilin genes (Extended Data Fig. 6b ) compared to the phenotypically wild-type egfl7 Δ4 allele 4 . Furthermore, vegfaa promoter-less mutants displayed a stronger central artery sprouting phenotype than vegfaa Δ10 mutants (Extended Data Fig. 6c) ; hbegfa RNA-less mutants displayed slow blood circulation-a phenotype not observed in hbegfa Δ7 mutants (Extended MEFs mESCs MKFs P = 1 × 10 -5 P = 3 × 10 -6 P = 6 × 10 -4 P = 6 × 10 -5 P = 2 × 10 -4 P = 0.002 P = 9 × 10 -5 P = 0.589
Relative expression levels Relative expression levels Fig. 6e ). Therefore, use of RNA-less alleles can uncover phenotypes that are not observed in alleles exhibiting mutant mRNA degradation.
Sequence similarity and transcriptional adaptation
Next, we performed transcriptome analysis of Fermt2, Actg1 and Actb knockout cells and observed that hundreds of genes were upregulated in the knockout cells compared to wild-type cells (Extended Data  Fig. 7a ). Only 81 genes were upregulated in all three of the knockout models, with no signs of a stress-induced response (Extended Data  Fig. 7b, c, Supplementary Table 1) . A first-pass analysis of the upregulated genes in each model showed that a disproportionate number of them exhibited sequence similarity with the mutated gene. We thus explored the relation between upregulation and sequence similarity based on several similarity thresholds (Extended Data Fig. 7d ; see the 'Sequence similarity and subsampling analyses' section of the Methods) and found a significant correlation. Using the optimal 'expect' (E) values to identify similar genes, we observed that at least 50% of them were significantly upregulated in the different knockout cell models, compared to a maximum of 21% of nonsimilar genes (Fig. 4a, Extended Data Fig. 8a-c) . Notably, seven of the twelve upregulated similar genes in Actg1 knockout cells were not upregulated in Actg1 RNA-less cells, and four of the six upregulated similar genes in Actb knockout cells were not upregulated in Actb RNA-less cells (Extended Data Fig. 8b, c) . We also observed that four of the nine similar genes that were not upregulated in Actg1 knockout cells at the mRNA level were upregulated at the pre-mRNA level (Extended Data Fig. 8d ). Additional studies showed that injection of uncapped mouse Actb RNA into zebrafish embryos led to an increase in zebrafish actb1 mRNA expression levels (Extended Data Fig. 8e , Supplementary Data), in line with the sequence similarity analyses mentioned above.
To begin to investigate how sequence similarity could have a role in transcriptional adaptation, we first injected uncapped transcripts containing only similar or non-similar sequences into zebrafish embryos. Using the hif1ab model, we observed that only transcripts containing sequences similar to epas1a led to an increase in epas1a mRNA expression levels (Fig. 4b, Extended Data Fig. 8f , Supplementary 
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W T vegfab, alcama and alcamb mRNA expression levels in zebrafish that lack the full hbegfa locus (full locus deletion; full locus del.) or the vegfaa or alcama promoter (promoter-less), compared to wild type. b, qPCR analysis of Rela, Rel, Actg1, Actg2, Actb and Actg1 mRNA expression levels in MEFs and mESCs that lack the Rela promoter or the full Actg1 or Actb locus, compared to wild-type cells. c, Cytotoxicity assay following TNF treatment of wild-type, Rela knockout and Rela promoter-less MEFs. Percentages are normalized relative to dimethyl sulfoxide (DMSO)-treated cells. d, Confocal microscopy of wild-type, Actb knockout and Actb full locus deletion mESCs. Actin filaments are depicted in white and nuclei in red (4′,6-diamidino-2-phenylindole (DAPI)). e, Actin filament protrusion length in wild-type, Actb knockout and Actb full locus deletion mESCs. f, Confocal micrographs of 48 hpf Tg(fli1a:eGFP) wild-type and egfl7 full locus deletion mutant zebrafish. Lateral views; anterior is to the left. Higher magnifications of the dashed boxes are shown in g. Scale bars, 20 µm (d); 500 µm (f). Wild-type expression levels were set at 1 (a, b). n = 3 (a, b); n = 5 (c); and n = 189 (wild type), 219 (Actb knockout) and 205 (Actb full locus deletion) (e) independent samples. Data are mean ± s.d., and a two-tailed Student's t-test was used to calculate P values. The experiments in d and f were repeated twice independently with similar results.
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Article reSeArcH Data). We also generated synthetic transcripts that contained hif1ab sequences similar to the promoter, exons, introns or 3′ untranslated region (UTR) of epas1a. Injection of uncapped versions of these transcripts revealed that those exhibiting sequence similarity with exons or introns induced transcriptional adaptation, whereas those exhibiting sequence similarity with the 3′UTR did not; and the transcripts exhibiting sequence similarity with the promoter induced only a mild response (Extended Data Fig. 8g ). These data are consistent with the transcriptome analyses of Fermt2, Actg1 and Actb knockout cells (Extended Data Fig. 8a -c)-genes that exhibited sequence similarity with the mutated gene's mRNA in their 3′UTR were not upregulated, and genes that exhibited sequence similarity with promoters displayed a mild upregulation or were not upregulated. Altogether, these data suggest that, at least in some cases, sequence similarity has a role in transcriptional adaptation.
Epigenetic remodelling in adapting genes
In the past decade, it has become evident that the control of mRNA stability has an important role in gene expression [10] [11] [12] [13] . Several studies have reported that mRNA decay factors can translocate to the nucleus and interact with histone modifiers and chromatin remodellers to modulate gene expression [14] [15] [16] [17] . We thus performed a targeted small interfering RNA (siRNA) screen in Rela knockout cells to identify epigenetic modulators that are involved in transcriptional adaptation (Supplementary Table 2 ). Knockdown of the histone lysine demethylases KDM4 or KDM6, which remove the inhibitory H3K9me3 or H3K27me3 histone marks, respectively, dampened the transcriptional adaptation response; however, the strongest effect was observed after WDR5 knockdown (Extended Data Fig. 9a ). WDR5 is part of the COMPASS complex, which generates the permissive histone mark H3K4me3. Chromatin immunoprecipitation (ChIP) revealed enrichment of WDR5 and H3K4me3 at the TSS of Fermt1, Rel and Actg2 in Fermt2, Rela and Actg1 knockout cells (Fig. 4c, d and Extended Data Fig. 9b) . Moreover, knockdown of UPF1/EXOSC4 or XRN1 in Rela knockout cells led to the depletion of H3K4me3 at the Rel TSS (Extended Data Fig. 9c) . Altogether, these data suggest a model in which concomitant with mutant mRNA degradation, decay factors translocate to the nucleus, where they bind to specific loci (possibly guided by decay intermediates) and recruit histone modifiers and/or chromatin remodellers to upregulate transcription ( Fig. 4e and Extended Data Fig. 9d) .
While investigating this model, we noted a study reporting that, in mESCs, transfection of short fragments of Cdk9 or Sox9 mRNA could lead to an increase in expression of these genes 18 . Mechanistically, these RNA fragments were found to downregulate native antisense transcripts that normally function as negative regulators of Cdk9 and Sox9 expression. Notably, we found that transfection of uncapped Cdk9 or Sox9 RNA also led to upregulation of these genes (Extended Data Fig. 10a ). Furthermore, in another study 19 , knockdown of a BDNF antisense transcript in HEK293T cells was reported to cause the upregulation of the sense transcript-a response that involved a decrease in the inhibitory H3K27me3 histone mark. We transfected HEK293T cells with uncapped BDNF sense RNA and observed a downregulation of the antisense transcript and a concomitant upregulation of the sense one (Extended Data  Fig. 10b) . Notably, we also observed a downregulation of antisense transcripts at the hbegfb and vclb loci in hbegfa Δ7 and vcla Δ13 mutants, respectively (Extended Data Fig. 10c, d ). These data indicate that acting on antisense transcripts is another possible mechanism through which mRNA decay intermediates could induce transcriptional adaptation in a sequence-specific manner ( Fig. 4e and Extended Data Fig. 9d ).
Discussion
Despite its potential importance 5 , transcriptional adaptation to mutations and its underlying molecular mechanisms remain poorly understood. Here we show that the mRNA surveillance machinery is important not only to prevent the translation of defective transcripts, but also to buffer against mutations by triggering the transcriptional upregulation of related genes, including the mutated gene itself (see Supplementary Discussion).
For several human genetic diseases, missense mutations or in-frame insertions or deletions (indels)-which are less likely to lead to mutant mRNA degradation-are reportedly more common than potentially mRNA-destabilizing nonsense mutations or out-of-frame indels [20] [21] [22] [23] [24] [25] . Of note, a study on patients with Marfan syndrome reported that when compared to individuals with FBN1 missense mutations, the mildest form of the disease was observed in an individual displaying very low mutant FBN1 transcript levels owing to an out-of-frame indel that led to a PTC in the FBN1 coding sequence 26 . Similar observations have been described for mutations in the HBB gene 27 . The current dogma is that pathogenic missense mutations tend to be more common in affected individuals because they might lead to constitutively active or dominant negative proteins. However, we propose that nonsense mutations are less common as they might result in mRNA decay-triggered upregulation of related genes and therefore not cause noticeable symptoms. Detailed transcriptomic analyses of relevant individuals will help to test this hypothesis. Moreover, studies 28, 29 of healthy individuals have reported homozygous loss-of-function mutations in several genes (including EGFL7 and RELA, the zebrafish and mouse homologues of which we studied here), and it will be interesting to investigate whether degradation of the mutant transcripts is associated with a transcriptional adaptation response that protects them. Such analyses may help us to understand why some mutations cause disease whereas others do not. They may also help in the identification of modifier genes, the expression levels of which could be further modulated for therapeutic purposes. 
Article reSeArcH
MEthodS
Statistics and reproducibility.
No statistical methods were used to predetermine sample size. The experiments were not randomized. The investigators were not blinded to allocation during experiments and outcome assessment. All experiments were performed at least twice unless otherwise noted. P < 0.05 was accepted as statistically significant. Zebrafish husbandry. All zebrafish (Danio rerio, strain: Tüb/AB) husbandry was performed under standard conditions in accordance with institutional (Max Planck Gesellschaft) and national ethical and animal welfare guidelines approved by the ethics committee for animal experiments at the Regierungspräsidium Darmstadt, Germany (permit number B2/1017). All experiments were performed on zebrafish embryos or larvae between 6 hpf and 6 days post-fertilization (dpf). We used the following previously published mutant and transgenic lines: hif1ab bns90 (ref. Wild-type and Rela knockout MEFs were a gift from A. Hoffmann. mESCs from the C57BL/6 mouse strain were a gift from J. Kim. None of the cell lines was authenticated by the authors. All cell lines tested negative for mycoplasma contamination.
Undifferentiated mESCs were maintained in PluriQ-ES-DMEM (MTIGlobalStem), consisting of high-glucose DMEM supplemented with 15% ES cell-qualified fetal bovine serum (Millipore), 2 mM glutamine, 1% non-essential amino acids, 100 U ml −1 penicillin, 100 µg ml −1 streptomycin, 0.1 mM β-mercaptoethanol and 1,000 U ml −1 ESGRO (LIF, Chemicon international) and 2i (3 µM CHIR99021 and 1 µM PD0325901, Sigma). mESCs were grown in 0.1% gelatin-coated plates and passaged every second day. MEFs and MKFs were cultured in DMEM (Thermo) supplemented with 10% bovine calf serum (HyClone), 100 U ml −1 penicillin and 100 µg ml −1 streptomycin. All cells were grown at 37 °C, 95% humidity with 5% CO 2 and experiments were performed on cells passaged fewer than 20 times. Genotyping. Heterozygous fish were incrossed; DNA and RNA were extracted from at least 24 individual embryos or larvae using TRIzol (Life Technologies) followed by phenol-chloroform extraction. In brief, single embryos or larvae were lysed and homogenized in TRIzol using a Next Advance Bullet Blender Homogenizer (Scientific Instrument Services). Chloroform was then added and phase separation was obtained following vortexing and centrifugation. The top aqueous phase (containing RNA) was isolated and stored at −80 °C and the bottom organic phase (containing DNA) was subjected to ethanol purification to precipitate the DNA. Purified DNA was then dissolved in water and genotyping was performed using high-resolution melt analysis or PCR. RNA from genotyped wild-type (+/+) and homozygous mutant (−/−)zebrafish was then pooled for further purification and cDNA synthesis. For each experiment, this process was performed on embryos from at least three different crosses.
High-resolution melt analysis was used to genotype all mutant zebrafish and mouse cell lines, with the exception of the RNA-less alleles, which were genotyped by PCR. The primer sequences used for genotyping are listed in Supplementary  Table 3 . qPCR expression analysis. qPCR was performed in a CFX Connect Real-Time System (Biorad). RNA was isolated using TRIzol and at least 500 ng RNA was used for reverse transcription using the Maxima First Strand cDNA synthesis kit (Thermo). All reactions were performed in at least technical duplicates and the results represent biological triplicates. qPCR was performed at the embryonic or larval stage when the wild-type version of the mutated gene exhibits its highest level of expression. For hbegfa mutants treated with the NMD inhibitor, data were analysed at 6 dpf and not at 72 hpf, as the drug seemed to be effective only when used for three days between 72 hpf and 6 dpf; treatment of earlier-stage embryos was not possible owing to toxicity. Primers were designed using Primer3 (http:// biotools.umassmed.edu/bioapps/primer3_www.cgi). Primers to detect pre-mRNA were designed to bind around intron-exon boundaries. Allele-specific primers were designed in such a way as to amplify the wild-type but not the mutant allele. To determine the injected capped and uncapped RNA levels, a universal reverse primer corresponding to the adaptor sequence at the 3′ end of the injected RNAs was used, along with forward primers designed in close proximity; in this way we were able to distinguish between endogenous and injected RNAs. Several primer pairs along the cDNA of the gene were used to assess transcription in the candidate promoter-less alleles. Only mutant alleles exhibiting less than 10% of wild-type mRNA levels with all the above mentioned primer pairs were used in the study. For the upf1 double mutant data, the figures show expression levels of the adapting gene in the double mutants relative to its expression levels in the upf1 single mutants. Expression levels of the mutated gene in the upf1 double mutants are relative to those in hbegfa, vegfaa or vcla single mutants. Equal numbers of cells were used for the cell line qPCR experiments. rpl13 and gapdh, and Actb, Rn18s and Gapdh, were used to normalize zebrafish and mouse experiments, respectively. rpl13 was chosen as a reference gene for zebrafish experiments as its expression levels were not changed between wild-type and egfl7 4 , hbegfa, vcla, vegfaa and alcama mutant embryos (unpublished microarray data). Primer sequences used for the qPCR experiments are listed in Supplementary Table 4 . Fold changes were calculated using the 2 −ΔΔCt method. All C t and ΔC t values are listed in the Source Data files. C t values for the reference genes ranged between 12 and 23 except for Rn18s, which ranged between 6 and 8. In vitro transcription and RNA microinjections. cDNAs encoding hif1ab, vegfaa, egfl7 and alcama full-length mRNAs were amplified using whole-embryo cDNA as a template. PCR fragments were ligated into a pCS2+ vector between BamHI and XbaI (NEB) sites. All constructs were verified by sequencing. Plasmids were linearized using NotI (NEB) and in vitro transcribed using the mMESSAGE mMA-CHINE SP6 kit (Life Technologies). RNA was then purified using an RNA Clean and Concentrator kit (Zymo Research). Approximately 10-100 pg of each mRNA was injected into embryos from heterozygous incrosses at the one-cell stage. At 22-30 hpf, embryos were collected in TRIzol for qPCR analysis.
To transcribe uncapped RNAs, cDNA was used to amplify zebrafish hif1ab and vegfaa and mouse Actb, whereas genomic DNA was used to amplify mouse Cdk9 and Sox9 (single exon for Cdk9 and the entire genomic locus (exons and introns) for Sox9) as their expression levels were too low to amplify from cDNA. In all cases, a reverse primer containing the adaptor sequence 5′-GCCAAGCTATTTAGGTGACACTATAG-3′ was used for amplification. A reverse primer containing only the adaptor sequence was subsequently used for qPCR detection of the injected transcripts, as described above. To generate uncapped XRN1-resistant transcripts, the XRN1-resistant sequence 8 was cloned upstream of the hif1ab and vegfaa coding sequences in pCS2+, and then linearized using NotI for in vitro transcription. In vitro synthesis of uncapped transcripts was performed using SP6 (or T7 in the case of the uncapped RNAs corresponding to the non-coding strand) RNA polymerase (Promega) and the RNA was purified using an RNA Clean and Concentrator kit. Alternatively, a T7 sequence was added to the forward primer of the PCR reaction and the product was directly used for in vitro synthesis of uncapped RNAs. The RNAs were injected into one-cell-stage zebrafish embryos (50 pg) or transfected into cells (1 µg) in 12-well plates. In vitro generation of synthetic transcripts containing different sequences of hif1ab mRNA. Oligonucleotides containing hif1ab sequences similar to epas1a were ligated together along with a 5′ T7 promoter sequence. Similar sequences were identified using a highly sensitive BLASTn analysis with a word size of 7 and an E value of up to 1,000,000. The alignment was visualized using Kablammo at the less sensitive E value of 25 owing to display constraints (Extended Data Fig. 8f ). The same approach was used to generate transcripts of hif1ab sequences that were not similar to epas1a, using the non-alignable sequences. In vitro transcription was performed using the T7 RNA polymerase (Promega). Guide RNA design. Guide RNAs (gRNAs) were designed using the CRISPR design tool CHOPCHOP (http://chopchop.cbu.uib.no/) 34 . To generate RNA-less alleles, double gRNAs were designed to flank the region to be deleted. gRNAs that were used to delete promoter regions were designed at least 500 bp upstream and downstream from the TSS of the respective gene. Sequences of the gRNAs used in this study and their genomic binding sites are listed in Supplementary Table 5 . Generation of zebrafish mutants. alcama mutant fish were generated using the TALEN technology 35, 36 . The other mutants were generated using the CRISPR-Cas9 system as previously described 37, 38 . To generate mutants, Cas9 mRNA (100 pg) and a gRNA targeting the gene of interest (50 pg) were co-injected into zebrafish embryos at the one-cell stage. To generate RNA-less alleles, two gRNAs were coinjected with Cas9 mRNA. The following mutants were generated for this study: 39, 40 . The other mutants were generated using the CRISPR-Cas9 system. gRNAs targeting Rela, Actg1 and Actb were cloned into the PX458 or PX459 vectors (Addgene; 48138 and 62988) as previously described 41 . The final bicistronic vector (hereafter referred to as nuclease plasmid) encoded the gRNA and the Cas9 nuclease. mESCs were transfected with nuclease plasmids in antibiotic-free medium in a 24-well plate using Xfect (Takara) according to the manufacturer's protocol, and transferred into a 10-cm dish the next day. Transfected cells were selected with 0.5 µg ml −1 puromycin (Sigma) for four days and clones were isolated and genotyped using high-resolution melt analysis and sequencing. MEFs were electroporated using Nucleofection (Lonza) with 5 µg nuclease plasmid DNA, according to the manufacturer's protocol. Two days after transfection, cells expressing eGFP were subjected to single-cell sorting into 96-well plates using a FACSAria III (BD Biosciences). Three to four weeks after single-cell sorting, clones were isolated and genotyped by PCR and sequencing. For generation of RNA-less alleles, cells were co-transfected with two nuclease plasmids.
Actg1 NSD (Actg1 knockout) and Actg1 full locus del. mutant MEFs do not exhibit any gross morphological defects. Overexpression plasmids. Fermt2 and Rela cDNAs were amplified using MEF cDNA as a template. PCR fragments were ligated into the pcDNA3.1 mammalian expression vector (Thermo) between the BamHI and XbaI sites. Plasmids were transfected into the respective knockout cells using FuGENE 6 (Promega) according to the manufacturer's protocol. Two days after transfection, cells were selected with 0.5 mg ml −1 and 2 mg ml −1 G418 (Sigma) for Fermt2 and Rela knockout cells, respectively. A week later, cells were lysed in modified radioimmunoprecipitation assay (RIPA) buffer for western blot analysis. Uncapped RNA transfections. Uncapped eGFP, Actb, Cdk9 and Sox9 RNAs were transfected into mESCs or MEFs using Lipofectamine Messenger Max (Thermo) transfection reagent according to the manufacturer's protocol. Six hours after transfection, cells were trypsinized and collected in TRIzol for RNA extraction. CRISPR interference. Three gRNAs targeting the Fermt2 promoter and TSS were each cloned into a plasmid encoding a fusion protein of catalytically dead Cas9 and Krüppel-associated box (KRAB) repressor (Addgene, 71237), as previously described 42 . Fermt2 knockout cells were transfected with the three plasmids and 48 h after transfection, cells positive for eGFP were sorted into TRIzol for RNA extraction. RNA interference. siRNAs are listed in Supplementary Table 2 . siRNA transfections were performed using the RNAiMAX transfection reagent (Thermo) according to the manufacturer's protocol. Forty-eight hours after transfection, cells were collected in TRIzol for RNA extraction, except for knockdowns of SMG6, ERF1 and XRN1 (in which cases cells were collected 24 h after transfection). In most cases, siRNAs were used at 10 nM and gave a knockdown efficiency of 70-90% (as assessed by mRNA levels). However, to knock down XRN1 in mESCs, a lower concentration of siRNAs was used (2.5 nM, which led to a knockdown efficiency of 20%) as stronger knockdown affected housekeeping genes as well (data not shown). A scrambled siRNA (Sigma, SIC00), which does not bind to any of the mouse transcripts, was used as a negative control.
For each experiment, the figures show expression levels of the adapting gene in knockout cells relative to its expression levels in wild-type cells that were treated with the same siRNA. Expression levels of the mutant gene in the knockout cells treated with a given siRNA are relative to those in knockout cells treated with scrambled siRNA. All C t and ΔC t values are shown in the Source Data files. Pharmacological treatments. To inhibit NMD, 72 hpf wild-type and hbegfa mutant larvae were treated with 10 µM NMDi14 43 or DMSO, and three days later, they were collected in TRIzol for qPCR analysis. No gross alterations were observed in the drug-treated larvae. To inhibit RNA degradation through translation blockade, wild-type and Rela knockout cells were treated with 200 µg ml −1 cycloheximide (Sigma) or DMSO for 5 h, then collected in TRIzol for RNA extraction.
For each experiment, the figures show expression levels of the adapting gene in mutant larvae or knockout cells, relative to its expression levels in wild-type larvae or cells that were treated with the same drug. Expression levels of the mutated gene in the mutant larvae, or knockout cells treated with a given drug, are relative to those in untreated mutant larvae, or knockout cells treated with DMSO. All C t and ΔC t values are shown in the Source Data files. RNA metabolic labelling. Metabolic labelling was performed as previously described 44, 45 . In brief, cells were treated with 200 µM 4-thiouridine (4sU; Sigma) for 1 h, followed by phenol-chloroform RNA extraction. RNA (80 µg) was incubated with biotin-HPDP (Thermo) to specifically biotinylate the newly transcribed 4sU-labelled RNAs. Biotinylated RNAs were then pulled down using the µMacs Streptavidin Kit (Miltenyi) and at least 100 ng of pulled down RNA was used for reverse transcription and downstream qPCR analysis. This experiment was performed once with two biological replicates. Quantifying mRNA half-lives by transcription inhibition. Wild-type, Fermt2 knockout, Rela knockout and Actg1 knockout cells were treated with 10 µg ml −1 actinomycin D (Sigma) to block transcription. Cells were then collected in TRIzol 0, 1, 2, 4 and 8 h after treatment for RNA extraction. Rn18s was used as a housekeeping gene, as its expression level was not affected over the time course of treatment (data not shown). Half-lives were then quantified from fitted nonlinear exponential decay curves. Cytotoxicity assay. Approximately 7,000 cells were seeded per well in a 96-well plate and incubated with media containing 25 ng ml −1 of mouse TNF. Twentyfour hours later, cells were washed with PBS and incubated for 5 h with media containing 3 mg ml −1 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT). The formed formazan (the product of MTT metabolism by viable cells) was resuspended in a 50% DMSO:50% ethanol solution, and optical density (O.D.) was measured at 572 nm using a FLUOstar Omega spectrophotometer (BMGH Labtech). Per cent cytotoxicity was measured using the following formula:
DMSO. This experiment was performed once. mESC staining. Cells were fixed with 4% paraformaldehyde for 15 min at room temperature, permeabilized with 0.3% Triton X-100 (in PBS) for 10 min and then incubated with 1:1,000 phalloidin-568 (Thermo) in 3% BSA for 1 h at room temperature. After 3 × 15 min washes with PBT (0.1% Triton X-100 in PBS), samples were counterstained for 5 min at room temperature with 1:5,000 DAPI (Sigma) and mounted for imaging with Dako fluorescent mounting medium. Images were obtained on a Zeiss LSM700 confocal microscope using an LD C-Apochromat 63×/1.15 W Corr M27 objective. Protrusion length was measured using ImageJ. Immunostaining. Larvae (100 hpf) from alcama promoter-less+/− and alcama
incrosses were collected and fixed in 4% paraformaldehyde. After removing the fixative with washes in 0.1% Tween in PBS, larvae were incubated with 3 µg ml −1 proteinase K for 1 h then washed with 1% BSA, 1%DMSO and 0.5% Triton-X in PBS (PBDT) before being incubated for 2 h with phalloidin Alexa-568 (Invitrogen) at room temperature to label F-actin. They were then washed with 0.1% Tween in PBS and mounted for heart imaging. Images of the hearts were acquired using a Zeiss LSM880 Axio Examiner confocal microscope with a W Plan-Apochromat 20×/1.0 objective. The ventricle length, or long axis of the ventricle, was measured from the apex of the ventricle to the junction of the ventricle with the bulbus arteriosus using Zen Black. In the first experiment, larvae were genotyped after imaging. alcama promoter-less larvae were obtained from F 2 heterozygous parents generated by outcrossing the founder and F 1 fish. alcama Δ8 larvae were obtained from an incross of F 3 heterozygous parents generated by consecutive outcrosses. Confocal microscopy. A Zeiss LSM 700 confocal microscope was used for live imaging of the trunk and brain vasculature in wild-type and egfl7 full locus del. , vegfaa Δ10 and vegfaa promoter-less mutant embryos. Embryos were anaesthetized with a low dose of tricaine, placed in a glass-bottomed Petri dish (MatTek) on a layer of 1.2% low melt agarose and imaged using Plan-Apochromat 10×/0.45 and LCI Plan-Neofluar 25×/0.8 objectives. In wild-type embryos at 60 hpf, an average of 13 central arteries have connected to the basilar artery 46 . vegfaa promoter-less larvae were obtained from F 2 heterozygous parents generated by outcrossing the founder and F 1 fish.
To measure blood flow velocity, we performed time-lapse imaging of the trunk region of 78 hpf wild-type, maternal zygotic hbegfa Δ7−/− and maternal zygotic hbegfa full locus del.−/− larvae using a Zeiss Spinning disc CSU-X1 confocal microscope with a high-speed camera, and quantified blood flow velocity in the dorsal aorta by measuring the time needed for erythrocytes to move 200 µm at the level of the fifth and sixth somites, using Zen Blue (as previously described) 47 . hbegfa full locus del. larvae were obtained from F 2 homozygous parents generated by outcrossing the founder. hbegfa Δ7 and vegfaa Δ10 larvae were obtained from an incross of F 3 heterozygous parents that were generated by consecutive outcrosses. Western blot analysis and antibodies. MKFs and MEFs were lysed in modified RIPA buffer (150 mM NaCl, 50 mM TrisHCl pH 7.4, 1% IGEPAL, 0.1% sodium deoxycholate, 1 mM EDTA) supplemented with protease inhibitors (cOmplete ULTRA Mini, Roche) and phenylmethylsulfonyl fluoride (PMSF). Protein samples of 35 µg were separated using sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) on precast TGX gradient gels (Biorad) (ACTB control was run on the same gel as a loading control) and then electrophoretically transferred to polyvinylidine fluoride membranes (Biorad) using a Transblot Turbo Transfer System (Biorad). Membranes for RELA or FERMT2 were blocked in 5% BSA (Sigma) or 5% non-fat milk (Sigma), respectively, for 1 h, then probed with primary antibodies overnight at 4 °C. The following day, membranes were probed with peroxidase-conjugated secondary antibodies for 1 h at room temperature. For analysis, membranes were incubated with enhanced chemiluminescence (ECL) substrate (Clarity Western ECL Substrate, Biorad) and imaged using a ChemiDoc MP system (Biorad). The following antibodies were used: FERMT2 (Millipore, MAB2617; clone 3A3, 1:1,000), RELA (Cell Signaling Technology, 6956, 1:1,000), ACTB (Cell Signaling Technology, 8457, 1:1,000), anti-mouse horseradish peroxidase (HRP)-conjugated IgG (Thermo, 31430, 1:10,000) and anti-rabbit HRPconjugated IgG (Thermo, 31460, 1:10,000). This experiment was performed once. Chromatin immunoprecipitation. ChIP was performed using the truChIP Chromatin Shearing Reagent kit (Covaris) using 30 million cells per immunoprecipitation according to the manufacturer's protocol. Chromatin was sheared using Bioruptor (Diagenode) to generate fragments of 200-400 bp in size. Immunoprecipitation was then performed as previously described 48 . The following antibodies were used: rabbit IgG (4 µg per immunoprecipitation, 026102, Thermo Fischer), WDR5 (4 µg per immunoprecipitation, 13105, Cell Signaling Technology) and H3K4me3 (4 µg per immunoprecipitation, 9751, Cell Signaling Technology). Following immunoprecipitation and reverse cross-linking, samples were purified using the NucleoSpin Gel and PCR Clean-up kit (Macherey-Nagel), according to the manufacturer's protocol for samples containing sodium dodecyl sulfate. ChIP-qPCR experiments on Rela knockout cells where UPF1/EXOSC4 or XRN1 were knocked down were performed only once. ATAC-seq material extraction and library preparation. Cells were trypsinized and washed with PBS. Counting of cells was performed with MOXI Z Mini Automated Cell Counter Kit (Orflo) and 50,000 cells were used for ATAC library preparation using the Tn5 transposase from the Nextera DNA Sample Preparation Kit (Illumina). The cell pellet was resuspended in 50 µl PBS and mixed with 25 µl tagmentation DNA (TD) buffer, 2.5 µl Tn5, 0.5 µl 10% NP-40 and 22 µl water. This mixture of Tn5 and cells was incubated at 37 °C for 30 min with occasional snap mixing. Transposase treatment was followed by 30 min incubation at 50 °C with 500 mM EDTA pH8.0 for optimal recovery of digested DNA fragments. For neutralization of EDTA, 100 µl of 50 mM MgCl 2 was added, followed by purification of the DNA fragments using the MinElute PCR Purification Kit (Qiagen). Amplification of the library together with indexing was performed as previously described 49 . Libraries were mixed in equimolar ratios and sequenced on a NextSeq500 platform using v2 chemistry. ATAC-seq analysis. The samples were assessed for quality using FastQC (http:// www.bioinformatics.babraham.ac.uk/projects/fastqc). Trimmomatic v.0.33 50 was used to trim reads after a quality drop below a mean of Q20 in a window of five nucleotides. Only reads above 30 nucleotides were cleared for further analyses. To normalize all samples to the same sequencing depth, 27 million reads per sample were randomly selected for further analysis. These reads were mapped against the Ensembl mouse genome version mm10 (GRCm38) with STAR 2.4.2a 51 using only unique alignments to exclude reads with unclear placing. The reads were further deduplicated using Picard 1.136 (http://broadinstitute.github.io/picard/) to avoid PCR artefacts leading to multiple copies of the same original fragment. The MACS2 peak caller v.2.1.0 was used to identify peaks. The minimum q value was set to −1.5 and the false discovery rate was changed to 0.01. To determine thresholds for significant peaks, the data were manually inspected in the Integrated Genomics Viewer (IGV) 2.3.52 52 . Peaks overlapping blacklisted regions (known mis-assemblies, satellite repeats) from ENCODE were excluded. To compare peaks between samples, the resulting lists of significant peaks were overlapped and unified to represent identical regions. After conversion of binary alignment map (BAM) files to bigWig format with deep Tools bamCoverage 53 , the counts per unified peak per sample were computed with bigWigAverageOverBed (UCSC Genome Browser Utilities, http://hgdownload.cse.ucsc.edu/downloads.html). Raw counts for unified peaks were submitted to DESeq2 for normalization 54 . Spearman correlations were produced to identify the degree of reproducibility between samples using R. To allow a normalized display of samples in IGV, the raw BAM files were normalized for sequencing depth (number of mapped deduplicated reads per sample) and noise level (number of reads inside peaks). Two factors were computed and applied to the original BAM files using bedtools genomecov 55 , resulting in normalized bigWig files for IGV. RNA sequencing. RNA was isolated using the miRNeasy micro Kit (Qiagen). To avoid contamination with genomic DNA, samples were treated by on-column DNase digestion (DNase-Free DNase Set, Qiagen). Total RNA and library integrity were verified on LabChip Gx Touch 24 (Perkin Elmer). One microgram of the total RNA was used as input for the SMARTer Stranded Total RNA Sample Prep Kit-HI Mammalian (Clontech). RNA sequencing (RNA-seq) was performed on a NextSeq500 instrument (Illumina) using v2 chemistry, resulting in an average of 25 million-30 million reads per library, with 1 × 75 bp single-end setup. RNA-seq analysis. The resulting raw reads were assessed for quality, adaptor content and duplication rates with FastQC. Reaper v.13-100 was used to trim reads after a quality drop below a mean of Q20 in a window of 10 nucleotides 56 . Only reads of at least 15 nucleotides were cleared for subsequent analyses. Trimmed and filtered reads were aligned against the Ensembl mouse genome version mm10 (GRCm38) using STAR 2.5.3a with the parameters '−outFilterMismatchNoverLmax 0.1−alignIntronMax 200000' 51 . The numbers of reads that aligned to genes were counted with featureCounts 1.6.0 from the Subread package 57 . Only reads mapping at least partially inside exons were admitted, and these reads were aggregated per gene. Reads overlapping with multiple genes or aligning to multiple regions were excluded. Differentially expressed genes were identified using DESeq2 v.1.14.1 58 . Genes were classified as significantly differentially expressed with P < 0.05 (Wald test), without assigning a specific minimum or maximum regulation fold change as transcriptional adaptation might not necessarily lead to strong upregulation levels. The Ensembl annotation was enriched with UniProt data (release 24 March 2017) based on Ensembl gene identifiers. Sequence similarity and subsampling analyses. To identify similarity to one of the three query nucleotide sequences (Fermt2, Actg1 and Actb), the longest respective transcript was selected (ENSMUST00000071555, ENSMUST00000045905 and ENSMUST00000100497) and compared to the whole genome using BLASTn 59 . Genes were defined to be similar to the mutated gene when a partial match was identified inside the target gene body or its promoter region (that is, 2 kb upstream of the TSS). Several alignment parameters were surveyed to identify the optimal degree of similarity. Alignment length, bit score and E value were queried to identify the dynamic range and optimal values using subsampling analyses (see below). E value denotes the probability that the match resulted by chance, when considering the whole target database (the genome in this case).
A subsampling approach was used to calculate a ranked P value for the significance of the percentage of upregulated genes in subsamples of a specific size (equivalent to the number of similar protein-coding genes) for each cell line model. In brief, the following algorithm was repeated 10,000 times: 1) get X random protein-coding genes, 2) calculate the percentage of upregulated genes in this subsample. The resulting list was filtered for subsamples with an equal or higher than expected number of upregulated genes according to a previous comparison (for example, for Fermt2, 18 protein-coding genes exhibit sequence similarity to its mRNA ( = subsample size), 9 of which were also upregulated ( = expectation)). The number of subsamples showing at least as many upregulated genes as the expectation represents the rank of the comparison. The ranked P value was computed by dividing that rank by the total number of iterations (= 10,000). Optimal thresholds varied for the different cell line models and ranged between 1) 20 and 180 nucleotides (alignment length); 2) 40 and 200 bit score (combination of alignment quality and length); and 3) 10 to 6.73 × 10 −50 (maximum E value). We selected the following maximum E values from the optimal range for the follow-up similarity analyses: 5.1 for Fermt2 and Actg1, and 2 × 10 −48 for Actb. The much stricter E value for Actb was necessary because of its repetitive 3′UTR, which resulted in misleading 'noisy' matches. These E-value thresholds translate into local nucleotide sequence alignments that range from 24 to 1,901 nucleotides in length, with 75 to 96% identity. Sequence alignments of hif1ab, Actb and epas1a. The BLASTn alignments of the longest transcript of hif1ab (ENSDART00000018500) with the epas1a gene body including its promoter (2 kb upstream of TSS) were visualized using Kablammo 60 at word size 7 and an E value of 25 (Extended Data Fig. 8f ). Two additional alignments were performed to show homologous regions of the synthetic hif1ab transcript compared to 1) the original source transcript (ENSDART00000018500), using MUSCLE 61 ; and 2) epas1a, including its promoter (TSS-2000), using BLASTn. The uncapped RNA composed solely of the hif1ab sequences that are similar to epas1a is 1,277 nucleotides in length, and the uncapped RNA composed solely of the hif1ab sequences that are not similar to epas1a is 1,929 nucleotides in length. The similarity of the coding sequences of zebrafish actb1 transcript ENSDART00000054987 (query) to the mouse Actb transcript ENSMUST00000100497 (subject) was assessed with a MUSCLE alignment. All of these alignments can be found in the Supplementary Data. Gene-set enrichment analyses. Genes that were strongly upregulated in all three knockout samples versus their respective wild-type samples (P < 0.05 (Wald test), log 2 (gene expression level in knockout cells/gene expression level in wild-type cells) (hereafter referred to as L2F) >0.585) were used for gene-set enrichment analyses using KOBAS 62 . Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
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